Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension

NACompletedINTERVENTIONAL
Enrollment

1,184

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 19, 2024

Study Completion Date

August 19, 2024

Conditions
Outcome
Interventions
DRUG

Alpha-Agonist

The maternal systolic blood pressure was consistently maintained above 80% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.

OTHER

α-adrenergic receptor agonist

The maternal systolic blood pressure was consistently maintained above 90% of the preoperative baseline value from the initiation of spinal anesthesia until fetal delivery.

Trial Locations (1)

750004

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT06151483 - Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension | Biotech Hunter | Biotech Hunter